Wang Jia Selected Research

gadofullerene

1/2021	A gadofullerene based liver-specific MRI contrast agent for an early diagnosis of orthotopic hepatocellular carcinoma.
10/2020	Functional Gadofullerene Nanoparticles Trigger Robust Cancer Immunotherapy Based on Rebuilding an Immunosuppressive Tumor Microenvironment.
1/2020	Gadofullerene Nanocrystals: A Robust, High-Efficiency Myelosuppressive Protector in Radiotherapy.
1/2020	Amino acid modified gadofullerene protects against insulin resistance induced by oxidative stress in 3T3-L1 adipocytes.
1/2020	Gadofullerene nanoparticles for robust treatment of aplastic anemia induced by chemotherapy drugs.
1/2020	Light-assisted gadofullerene nanoparticles disrupt tumor vasculatures for potent melanoma treatment.
1/2017	Amino acid functionalized gadofullerene nanoparticles with superior antitumor activity via destruction of tumor vasculature in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wang Jia Research Topics

Disease

30	Neoplasms (Cancer) 06/2022 - 06/2013
11	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 06/2008
10	Glioma (Gliomas) 01/2021 - 11/2015
6	Neoplasm Metastasis (Metastasis) 03/2021 - 06/2013
2	Pain (Aches) 06/2022 - 11/2011
2	Epilepsy (Aura) 01/2022 - 01/2020
2	Hemorrhage 01/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 03/2021 - 12/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2017
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 10/2018
2	Adenoma (Adenomas) 09/2020 - 01/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 02/2019
2	Meningioma (Meningiomas) 01/2020 - 01/2020
2	Carcinogenesis 10/2018 - 11/2014
2	Brain Neoplasms (Brain Tumor) 03/2018 - 03/2014
1	Ganglion Cysts (Ganglion) 06/2022
1	Pituitary Diseases (Disease, Anterior Pituitary) 01/2022
1	Infections 01/2022
1	Hypertensive Intracranial Hemorrhage 01/2022
1	Ischemic Stroke 01/2022
1	Hematoma 01/2022
1	Reperfusion Injury 10/2021
1	Hearing Loss (Hearing Impairment) 09/2021
1	Acoustic Neuroma (Acoustic Neurinoma) 09/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Testicular Neoplasms (Testicular Cancer) 09/2020
1	Inflammation (Inflammations) 08/2020
1	Silicosis 08/2020
1	Occupational Diseases (Occupational Disease) 08/2020
1	Lung Injury 08/2020
1	Pneumonia (Pneumonitis) 08/2020
1	Radiation Injuries (Radiation Sickness) 01/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Gliosis 01/2020
1	Hepatomegaly 01/2020
1	Insulin Resistance 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Metabolic Diseases (Metabolic Disease) 01/2020
1	Necrosis 01/2020
1	Obesity 01/2020

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 03/2021 - 06/2013
7	gadofullereneIBA 01/2021 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 09/2021 - 05/2015
4	Growth Hormone (Somatotropin)IBA 09/2020 - 05/2015
4	Indicators and Reagents (Reagents)IBA 09/2018 - 09/2013
3	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2018
3	Biological ProductsIBA 09/2020 - 08/2013
3	Alanine (L-Alanine)FDA Link 08/2020 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2020
3	ProlactinIBA 10/2018 - 05/2015
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2020
2	Amino Acids FDA Link 01/2020 - 01/2017
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 10/2018
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2020
2	Messenger RNA (mRNA)IBA 12/2019 - 10/2018
2	mesoglycanIBA 11/2018 - 10/2018
2	Claudin-5IBA 12/2017 - 03/2014
1	small cardioactive peptide BIBA 06/2022
1	Opioid Analgesics (Opioids)IBA 06/2022
1	Retinaldehyde (Retinal)IBA 06/2022
1	CollagenIBA 11/2021
1	sulforaphaneIBA 10/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Contrast MediaIBA 01/2021
1	hydroxide ionIBA 01/2021
1	AntigensIBA 09/2020
1	fullerene C70IBA 08/2020
1	Hydroxyl RadicalIBA 08/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 08/2020
1	FullerenesIBA 08/2020
1	Member 2 Solute Carrier Family 12IBA 01/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020
1	phytochlorinIBA 01/2020
1	cadherin 5IBA 01/2020
1	TensinsIBA 01/2020
1	AntioxidantsIBA 01/2020
1	Bumetanide (Bumex)FDA LinkGeneric 01/2020
1	CalpainIBA 01/2020
1	FructoseIBA 01/2020
1	GangliosidesIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	LipidsIBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020

Therapy/Procedure

10	Therapeutics 01/2020 - 01/2015
5	Craniotomy 06/2022 - 06/2008
4	Immunotherapy 10/2020 - 01/2018
4	Radiotherapy 01/2020 - 03/2014
3	Drug Therapy (Chemotherapy) 01/2020 - 03/2014
2	Analgesia 06/2022 - 11/2011
2	Operative Time 01/2022 - 11/2011
1	Anesthesia 06/2022
1	Punctures 01/2022
1	Traction 09/2020